Adin Ermie
Massachusetts-based, Lucy Therapeutics, a bio-tech startup raised $12.5 million led by Safar Partners and Engine Ventures in funding.
CEO Lucy Therapeutics, Amy Ripka said in a media breefing that the raised funds will be used for advance research in Parkinson’s and Alzheimer’s diseases and expansion.
Moreover, Lucy Therapeutics has more than 3 programs in pipeline for advance drugs discovery, also IND filings planed for 2025.